CRANBURY, N.J., Oct. 26 /PRNewswire-FirstCall/ -- Amicus Therapeutics will announce third quarter 2009 financial results after the regular close of markets on Thursday, October 29, 2009. The results announcement will be followed by a live conference call and webcast that afternoon at 5:30 p.m. EDT.
An audio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, an audio webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.
About Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs.
CONTACT: Jenene Thomas of Amicus Therapeutics, +1-609-662-5084,
jthomas@amicustherapeutics.com
Web site: http://www.amicustherapeutics.com//
